论文部分内容阅读
在上海技术交易所,一对夫妇出价1500万元,买下了注册资本仅680万元,亏损500万元的宝合包装印刷公司。上海永信维生素公司因研发费用巨大导致效益下降,原先的两家风险投资机构急欲脱手,一位姓徐的个人投资者斥资2500万元,受让永信71.75%的股权。他说:“我买这家企业进退有道。进,开发新产品,我有医药销售渠道;退.目前市场上维生素保健品方兴未艾,从维生素用药转向保健品技术没问题,企业有很大商机。”近年来越来越多个人投资者对投资科技企业相当感兴趣,上海
In Shanghai Technology Exchange, a couple bid 15 million yuan, bought a registered capital of only 6.8 million yuan, a loss of 5 million yuan Po-packaging printing company. Shanghai Wing letter vitamin company due to huge research and development costs led to the decline in efficiency, the original two venture capital agencies are anxious to sell, a surnamed Xu’s individual investors spend 25 million yuan, 71.75% of the shares transferred Wing Shun. He said: “I bought this business advance and retreat proper .Indevelopment of new products, I have the medical sales channels; retreat. Currently on the market vitamin health products in the ascendant, from vitamin medication to health products technology no problem, companies have great Business Opportunities. ”In recent years, more and more individual investors are quite interested in investing in science and technology enterprises. Shanghai